Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
25
PBCRY Quote, Financials, Valuation and Earnings
Last price:
$13.34
Seasonality move
:
4.31%
Day range:
$12.57 - $13.15
52-week range:
$11.27 - $18.28
Dividend yield:
3.44%
P/E ratio:
18.43x
P/S ratio:
9.21x
P/B ratio:
4.36x
Volume:
77.2K
Avg. volume:
89.5K
1-year change:
-15.83%
Market cap:
$64.5B
Revenue:
$7B
EPS (TTM):
$0.71
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, PT Bank Central Asia Tbk has -- downside to fair value with a price target of -- per share.
PBCRY vs. S&P 500
-
Over the past 5 trading days, PT Bank Central Asia Tbk has underperformed the S&P 500 by -1.2% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
PT Bank Central Asia Tbk does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
PT Bank Central Asia Tbk has grown year-over-year revenues for 16 quarters straight. In the most recent quarter PT Bank Central Asia Tbk reported revenues of $1.7B.
Earnings Growth
-
PT Bank Central Asia Tbk has grown year-over-year earnings for 17 quarters straight. In the most recent quarter PT Bank Central Asia Tbk reported earnings per share of $0.17.
Enterprise value:
57.7B
EV / Invested capital:
--
Price / LTM sales:
9.21x
EV / EBIT:
11.62x
EV / Revenue:
8.23x
PEG ratio (5yr expected):
2.43x
EV / Free cash flow:
17.15x
Price / Operating cash flow:
19.18x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
3.86%
Net Income Margin (TTM):
49.89%
Return On Equity:
22.76%
Return On Invested Capital:
22.51%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $6.2B | $6.6B | $7B | $1.7B | $1.7B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $0.59 | $0.66 | $0.71 | $0.17 | $0.17 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $19.4B | $26.8B | $20.9B | $15.4B | $10.1B | |
| Total Assets | $74.1B | $88.2B | $88.6B | $91B | $92B | |
| Current Liabilities | $500.9M | $588.5M | $379.3M | $774.2M | $848.1M | |
| Total Liabilities | $62B | $74.5B | $74.4B | $76.6B | $77.2B | |
| Total Equity | $12.2B | $13.6B | $14.2B | $14.3B | $14.8B | |
| Total Debt | $104.5M | $142.5M | $149.8M | $129.7M | $216.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $5.3B | $4.1B | $3.6B | $1.9B | $2.1B | |
| Cash From Investing | -$3.8B | -$3.7B | -$3.2B | -$796.8M | -$261.8M | |
| Cash From Financing | -$1.3B | -$1.7B | -$2.1B | -$12.3M | -$132.7K | |
| Free Cash Flow | $5B | $3.8B | $3.4B | $1.9B | $2.1B | |
PBCRY
Sector
Market Cap
$64.5B
$627.9M
Price % of 52-Week High
71.54%
89.42%
Dividend Yield
3.44%
1.97%
Shareholder Yield
--
4.06%
1-Year Price Total Return
-15.83%
7.77%
Beta (5-Year)
0.497
0.585
Dividend yield:
3.44%
Annualized payout:
$0.44
Payout ratio:
61.7%
Growth streak:
10 years
Technicals
8-day SMA
Sell
Level
$13.22
200-day SMA
Sell
Level
$14.54
Bollinger Bands (100)
Sell
Level
12.74 - 14.06
Chaikin Money Flow
Sell
Level
-58.4K
20-day SMA
Sell
Level
$13.32
Relative Strength Index (RSI14)
Sell
Level
39.31
ADX Line
Sell
Level
26.37
Williams %R
Neutral
Level
-64.3855
50-day SMA
Sell
Level
$13.80
MACD (12, 26)
Buy
Level
3.59
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Sell
Level
-489.4K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.178)
Sell
CA Score
(Annual)
Level (-1.6714)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (6)
Sell
Ohlson Score
Level (0.4133)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
PT Bank Central Asia Tbk is an Indonesia-based banking service provider operating as a Sharia bank. The bank provides various financial solutions to its customers through its inter-branch links, ATM network, and electronic banking services. It offers loans, deposit accounts, mutual fund investments, fixed income products, and credit facilities, among other banking products and services. Its segments are Loans, which derives maximum revenue, Treasury, and Others. The customer base mainly includes individuals, small and medium businesses, and corporations. Its business segment is classified into five geographic areas, which are Sumatera, Java, Kalimantan, East Indonesia, and overseas operations.
Stock Forecast FAQ
In the current month, PBCRY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PBCRY average analyst price target in the past 3 months is --.
-
Where Will PT Bank Central Asia Tbk Stock Be In 1 Year?
According to analysts, the consensus estimate is that PT Bank Central Asia Tbk share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About PT Bank Central Asia Tbk?
Analysts are divided on their view about PT Bank Central Asia Tbk share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PT Bank Central Asia Tbk is a Sell and believe this share price will rise from its current level to --.
-
What Is PT Bank Central Asia Tbk's Price Target?
The price target for PT Bank Central Asia Tbk over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PBCRY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for PT Bank Central Asia Tbk is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of PBCRY?
You can purchase shares of PT Bank Central Asia Tbk via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PT Bank Central Asia Tbk shares.
-
What Is The PT Bank Central Asia Tbk Share Price Today?
PT Bank Central Asia Tbk was last trading at $13.34 per share. This represents the most recent stock quote for PT Bank Central Asia Tbk. Yesterday, PT Bank Central Asia Tbk closed at $13.08 per share.
-
How To Buy PT Bank Central Asia Tbk Stock Online?
In order to purchase PT Bank Central Asia Tbk stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
